systematic_review
    2012

    Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders

    Kelesidis T, Pothoulakis C

    Published in Therapeutic Advances in Gastroenterology

    Key Findings

    Evidence supports S. boulardii for antibiotic-associated and travellers diarrhoea, with rare fungemia reported almost exclusively in critically ill or catheterised patients.

    Conclusions

    Generally safe in healthy adults but avoid in immunocompromised or central-line patients.

    Limitations

    Narrative synthesis of heterogeneous indications.

    Supplements Studied

    Rare fungemia reported almost exclusively in critically ill or catheterised patients.

    Study Details

    Year:2012
    00
    Quality Score:6/10

    Access Study

    View on DOIOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.